VCI Wealth Management LLC Invests $672,000 in Kenvue Inc. $KVUE

VCI Wealth Management LLC acquired a new position in Kenvue Inc. (NYSE:KVUE) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 41,401 shares of the company’s stock, valued at approximately $672,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in KVUE. Trust Co. of Vermont raised its position in Kenvue by 266.8% in the second quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock worth $33,000 after acquiring an additional 1,150 shares during the period. Truvestments Capital LLC purchased a new stake in shares of Kenvue in the 1st quarter worth $37,000. Future Financial Wealth Managment LLC bought a new position in Kenvue in the 3rd quarter worth $49,000. First Pacific Financial bought a new position in Kenvue in the 2nd quarter worth $54,000. Finally, Ransom Advisory Ltd purchased a new position in Kenvue during the first quarter valued at $56,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Kenvue

In related news, Director Jeffrey C. Smith acquired 3,200,000 shares of the company’s stock in a transaction on Friday, December 12th. The stock was acquired at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the acquisition, the director directly owned 27,307,632 shares of the company’s stock, valued at approximately $474,333,567.84. This trade represents a 13.27% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. 1.68% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of brokerages have commented on KVUE. Deutsche Bank Aktiengesellschaft set a $18.00 price target on Kenvue in a research report on Friday, October 24th. Zacks Research raised shares of Kenvue from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. UBS Group lowered their price target on shares of Kenvue from $23.00 to $17.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. Weiss Ratings reissued a “hold (c-)” rating on shares of Kenvue in a research note on Tuesday, October 14th. Finally, Johnson Rice restated a “neutral” rating on shares of Kenvue in a research report on Tuesday, October 28th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and twelve have issued a Hold rating to the company. Based on data from MarketBeat, Kenvue has an average rating of “Hold” and a consensus price target of $20.23.

Kenvue Trading Up 0.5%

KVUE stock opened at $17.11 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $25.17. The business has a 50 day simple moving average of $16.40 and a two-hundred day simple moving average of $18.76. The company has a market capitalization of $32.78 billion, a price-to-earnings ratio of 22.81 and a beta of 0.60.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.01. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The firm had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.83 billion. During the same quarter last year, the business posted $0.28 earnings per share. The company’s revenue for the quarter was down 3.5% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Research analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th were paid a $0.2075 dividend. The ex-dividend date was Wednesday, November 12th. This represents a $0.83 annualized dividend and a yield of 4.9%. Kenvue’s payout ratio is presently 110.67%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.